Table 6. OS after first-line ET according to prior adjuvant chemotherapy.
|
Multivariate analysis |
||||||||
|---|---|---|---|---|---|---|---|---|
| Prior adjuvant chemotherapy | No. of patients | Median OS months (95% CI) | P-value | Hazard ratio | 95% CI | χ2 | df | P-value |
| None | 101 | 27.5 (19.9–35.1) | 1 (ref) | |||||
| CMF | 109 | 23.8 (19.1–28.5) | 1.16 | 0.68–1.99 | ||||
| Anthracycline | 81 | 20.2 (16.4–24.0) | 1.35 | 0.78–2.33 | 1.24 | 2 | ||
| 0.61 | 0.54 | |||||||
| All patients | 291 | 24.1 (16.4–35.1) | ||||||
OS=overall survival; ET=epirubicin/paclitaxel; CI=Confidence interval; df=degree of freedom; CMF=Cyclophosplamide plus methotrexate plus 5-fluorouracil.